|
PARD6B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.352240E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.521600E-02 |
| Normal-vs-Stage2 |
3.621000E-01 |
| Normal-vs-Stage3 |
8.396000E-01 |
| Normal-vs-Stage4 |
4.948200E-01 |
| Stage1-vs-Stage2 |
6.884000E-01 |
| Stage1-vs-Stage3 |
3.309000E-01 |
| Stage1-vs-Stage4 |
7.105000E-01 |
| Stage2-vs-Stage3 |
5.091600E-01 |
| Stage2-vs-Stage4 |
9.479600E-01 |
| Stage3-vs-Stage4 |
5.854800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.000000E-01 |
| Normal-vs-AfricanAmerican |
1.803410E-01 |
| Normal-vs-Asian |
3.824300E-02 |
| Caucasian-vs-AfricanAmerican |
6.858800E-01 |
| Caucasian-vs-Asian |
3.838000E-01 |
| AfricanAmerican-vs-Asian |
3.192600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.375220E-01 |
| Normal-vs-Female |
3.108400E-01 |
| Male-vs-Female |
9.608400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.004000E-01 |
| Normal-vs-Extreme_Weight |
1.674120E-02 |
| Normal-vs-Obese |
9.286200E-01 |
| Normal-vs-Extreme_Obese |
6.578600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.926800E-01 |
| Normal_Weight-vs-Obese |
3.536800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.468600E-01 |
| Extreme_Weight-vs-Obese |
4.280500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.693400E-01 |
| Obese-vs-Extreme_Obese |
7.976600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.527800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.878200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.191800E-02 |
| Normal-vs-Age(81-100Yrs) |
1.953910E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.412800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.872200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.074620E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.624200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.798300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.179800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.285800E-01 |
| Normal-VS-Type2 PRCC |
1.497000E-01 |
| Normal-VS-KIRP CIMP |
1.221850E-02 |
| Normal-VS-Unclassified PRCC |
5.227000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.651600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.340400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.243600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.561200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.165590E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.582410E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.173400E-01 |
| Normal-vs-N1 |
9.406000E-01 |
| Normal-vs-N2 |
3.350400E-02 |
| N0-vs-N1 |
2.844000E-01 |
| N0-vs-N2 |
8.142100E-02 |
| N1-vs-N2 |
4.984800E-03 |
|
|
